These 2 Passive Income Stars Just Declared Dividend Raises
Investors are now in the midst of the final earnings season of 2022. Companies often cap their reporting year with a dividend raise, and the raising has been relatively brisk lately. Businesses of every size and in every sector are adding to their payouts.
Two giants in their respective industries, AbbVie (NYSE: ABBV) and Visa (NYSE: V), are among that group of lifters. Let's take a closer look at these two companies' still-fresh dividend increases -- and why it could make them attractive for investors.
Being the developer of the world's top-selling drug sure has its privileges. AbbVie is the company behind Humira, the blockbuster treatment for rheumatoid arthritis and a set of other afflictions whose sales approached a staggering $20 billion-plus last year.
Source Fool.com
